Thomas K. Dreyer

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Reply to Behzad Jazayeri, Xuefeng Wang, and Roger Li's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30.

Reply to Behzad Jazayeri, Xuefeng Wang, and Roger Li's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30.

Journal: European urology

Published: September 25, 2025

Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30.

Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30.

Journal: European urology

Published: September 03, 2025

Reply to Xin Rui, Xiaoming Xu, and Bo Dai's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. 2025;88:23-30.

Reply to Xin Rui, Xiaoming Xu, and Bo Dai's Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. 2025;88:23-30.

Journal: European urology

Published: May 28, 2025

Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial.

Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial.

Journal: European urology

Published: September 30, 2024

Response to Letter re "Long-term outcomes of foreskin reconstruction in distal hypospadias; a cohort study spanning twenty years".

Response to Letter re "Long-term outcomes of foreskin reconstruction in distal hypospadias; a cohort study spanning twenty years".

Journal: Journal of pediatric urology

Published: December 28, 2023

DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer.

DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer.

Journal: Scandinavian journal of urology

Published: October 19, 2023

Long-term outcomes of foreskin reconstruction in distal hypospadias; a cohort study spanning twenty years.

Long-term outcomes of foreskin reconstruction in distal hypospadias; a cohort study spanning twenty years.

Journal: Journal of pediatric urology

Published: July 26, 2023

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial.

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial.

Journal: Cancers

Published: March 15, 2023

Impact of ischemia time during partial nephrectomy on short- and long-term renal function.

Impact of ischemia time during partial nephrectomy on short- and long-term renal function.

Journal: Scandinavian journal of urology

Published: January 28, 2023

Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safety.

Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safety.

Journal: Scandinavian journal of urology

Published: December 16, 2021

Which data are available in central registries on bladder cancer patients in the five Nordic countries.

Which data are available in central registries on bladder cancer patients in the five Nordic countries.

Journal: Scandinavian journal of urology

Published: January 28, 2021

Targeting the Acidic Tumor Microenvironment: Unexpected Pro-Neoplastic Effects of Oral NaHCO3 Therapy in Murine Breast Tissue.

Targeting the Acidic Tumor Microenvironment: Unexpected Pro-Neoplastic Effects of Oral NaHCO3 Therapy in Murine Breast Tissue.

Journal: Cancers

Published: February 20, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026